 |
Sorafenib |
|---|---|
| Trade Name | Nexavar |
| Orphan Indication | Renal cancer |
| USA Market Approval | USA |
| USA Designation Date | 2004-10-08 00:00:00 |
| Sponsor | Bayer Pharmaceutical Corporation;400 Morgan Lane;West Haven, Connecticut, 06516 |
| |
Sorafenib |
|---|---|
| Trade Name | Nexavar |
| Orphan Indication | Renal cancer |
| USA Market Approval | USA |
| USA Designation Date | 2004-10-08 00:00:00 |
| Sponsor | Bayer Pharmaceutical Corporation;400 Morgan Lane;West Haven, Connecticut, 06516 |